- preweaning lethality, incomplete penetrance / IMPC
- enlarged spleen / IMPC
- enlarged cecum / IMPC
- hyperactivity / IMPC
- abnormal skin morphology / IMPC
- decreased thigmotaxis / IMPC
- edema / IMPC
- abnormal behavior / IMPC
- abnormal spleen morphology / IMPC
- abnormal kidney morphology / IMPC
- preweaning lethality, complete penetrance / IMPC
- small kidney / IMPC
- abnormal cecum morphology / IMPC
- increased bone mineral content / IMPC
- abnormal skin morphology / IMPC
B6.129-Cnr1tm1Zim Cnr2tm1Zim/Ieg
Status | Available to order |
EMMA ID | EM:02273 |
Citation information | RRID:IMSR_EM:02273 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.129-Cnr1tm1Zim Cnr2tm1Zim/Ieg |
Alternative name | Cnr1 tm1zim/ Cnr2 tm2zim |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Cnr1tm1Zim, Cnr2tm1Zim |
Gene/Transgene symbol | Cnr1, Cnr2 |
Information from provider
Provider | Andreas Zimmer |
Provider affiliation | Institute of Molecular Psychiatry |
Genetic information | See references: PubMed_ID 10318961 and PubMed_ID 10822068. |
Phenotypic information | Allergic contact dermatitis. |
References |
|
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | homozygous C57BL/6N males |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- hypoactivity / MGI
- increased circulating corticosterone level / MGI
- increased thermal nociceptive threshold / MGI
- premature death / MGI
- decreased vertical activity / MGI
- catalepsy / MGI
- hypoalgesia / MGI
- maternal effect / MGI
- increased follicle stimulating hormone level / MGI
- increased circulating estradiol level / MGI
- decreased circulating progesterone level / MGI
- increased chemical nociceptive threshold / MGI
- decreased survivor rate / MGI
- impaired behavioral response to addictive substance / MGI
- postnatal lethality, incomplete penetrance / MGI
- early parturition / MGI
- abnormal macrophage physiology / MGI
- immune system phenotype / MGI
- reproductive system phenotype / MGI
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- abnormal cerebral cortex morphology / MGI
- decreased body weight / MGI
- weight loss / MGI
- increased aggression towards mice / MGI
- increased anxiety-related response / MGI
- hyperactivity / MGI
- hypoactivity / MGI
- increased exploration in new environment / MGI
- decreased exploration in new environment / MGI
- abnormal cued conditioning behavior / MGI
- reduced long term depression / MGI
- increased circulating corticosterone level / MGI
- increased circulating adrenocorticotropin level / MGI
- absent long term depression / MGI
- increased thermal nociceptive threshold / MGI
- increased chemically-elicited antinociception / MGI
- decreased chemically-elicited antinociception / MGI
- abnormal learning/memory/conditioning / MGI
- premature death / MGI
- no abnormal phenotype detected / MGI
- abnormal social/conspecific interaction / MGI
- abnormal sperm motility / MGI
- decreased circulating insulin level / MGI
- decreased vertical activity / MGI
- abnormal active avoidance behavior / MGI
- catalepsy / MGI
- increased insulin sensitivity / MGI
- increased susceptibility to pharmacologically induced seizures / MGI
- abnormal excitatory postsynaptic potential / MGI
- decreased synaptic depression / MGI
- abnormal paired-pulse facilitation / MGI
- abnormal inhibitory postsynaptic currents / MGI
- enhanced long term potentiation / MGI
- no phenotypic analysis / MGI
- hypoalgesia / MGI
- increased susceptibility to ischemic brain injury / MGI
- abnormal depression-related behavior / MGI
- abnormal response to novel object / MGI
- nervous system phenotype / MGI
- abnormal nervous system morphology / MGI
- abnormal nervous system physiology / MGI
- maternal effect / MGI
- abnormal nervous system development / MGI
- abnormal sweet taste sensitivity / MGI
- abnormal neuron physiology / MGI
- abnormal synaptic plasticity / MGI
- abnormal neuronal precursor proliferation / MGI
- increased follicle stimulating hormone level / MGI
- increased circulating estradiol level / MGI
- decreased circulating progesterone level / MGI
- behavior/neurological phenotype / MGI
- skeleton phenotype / MGI
- abnormal food intake / MGI
- decreased percent body fat/body weight / MGI
- decreased susceptibility to diet-induced obesity / MGI
- decreased circulating leptin level / MGI
- increased cerebral infarction size / MGI
- increased susceptibility to neuronal excitotoxicity / MGI
- increased chemical nociceptive threshold / MGI
- decreased survivor rate / MGI
- increased physiological sensitivity to xenobiotic / MGI
- abnormal axon fasciculation / MGI
- impaired cued conditioning behavior / MGI
- anhedonia / MGI
- impaired conditioned place preference behavior / MGI
- impaired behavioral response to xenobiotic / MGI
- impaired behavioral response to addictive substance / MGI
- impaired behavioral response to morphine / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- increased sensitivity to xenobiotic induced morbidity/mortality / MGI
- increased behavioral withdrawal response / MGI
- decreased total body fat amount / MGI
- abnormal bone mineral density / MGI
- postnatal lethality, incomplete penetrance / MGI
- early parturition / MGI
- alopecia / MGI
- abnormal macrophage physiology / MGI
- immune system phenotype / MGI
- reproductive system phenotype / MGI
Literature references
- Attenuation of allergic contact dermatitis through the endocannabinoid system.;Karsak Meliha, Gaffal Evelyn, Date Rahul, Wang-Eckhardt Lihua, Rehnelt Jennifer, Petrosino Stefania, Starowicz Katarzyna, Steuder Regina, Schlicker Eberhard, Cravatt Benjamin, Mechoulam Raphael, Buettner Reinhard, Werner Sabine, Di Marzo Vincenzo, Tüting Thomas, Zimmer Andreas, ;2007;Science (New York, N.Y.);316;1494-7; 17556587
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.;Járai Z, Wagner J A, Varga K, Lake K D, Compton D R, Martin B R, Zimmer A M, Bonner T I, Buckley N E, Mezey E, Razdan R K, Zimmer A, Kunos G, ;1999;Proceedings of the National Academy of Sciences of the United States of America;96;14136-41; 10570211
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).